These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12573306)

  • 1. Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia.
    Anderer P; Semlitsch HV; Saletu B; Saletu-Zyhlarz G; Gruber D; Metka M; Huber J; Gräser T; Oettel M
    Psychoneuroendocrinology; 2003 Apr; 28(3):419-45. PubMed ID: 12573306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials.
    Anderer P; Saletu B; Saletu-Zyhlarz G; Gruber D; Metka M; Huber J; Pascual-Marqui RD
    Neuropsychobiology; 2004; 49(3):134-53. PubMed ID: 15034229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients.
    Saletu B; Anderer P; Gruber D; Metka M; Huber J; Saletu-Zyhlarz GM
    Maturitas; 2002 Nov; 43(3):165-81. PubMed ID: 12443834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone.
    Saletu-Zyhlarz G; Anderer P; Gruber G; Mandl M; Gruber D; Metka M; Huber J; Oettel M; Gräser T; Abu-Bakr MH; Grätzhofer E; Saletu B
    J Sleep Res; 2003 Sep; 12(3):239-54. PubMed ID: 12941063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.
    Linzmayer L; Semlitsch HV; Saletu B; Böck G; Saletu-Zyhlarz G; Zoghlami A; Gruber D; Metka M; Huber J; Oettel M; Gräser T; Grünberger J
    Arzneimittelforschung; 2001; 51(3):238-45. PubMed ID: 11304940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
    Saletu B
    Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of antiandrogens in hormone replacement therapy.
    Schneider HP
    Climacteric; 2000 Dec; 3 Suppl 2():21-7. PubMed ID: 11379383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints.
    Gräser T; Römer T; Wiedey KD; Janaud A
    Climacteric; 2001 Dec; 4(4):332-42. PubMed ID: 11770190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
    Gräser T; Koytchev R; Müller A; Oettel M
    Climacteric; 2000 Jun; 3(2):109-18. PubMed ID: 11910651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying target regions for vigilance improvement under hormone replacement therapy in postmenopausal syndrome patients by means of electroencephalographic tomography (LORETA).
    Saletu B; Anderer P; Saletu-Zyhlarz GM; Gruber D; Metka M; Huber J
    Psychopharmacology (Berl); 2005 Apr; 178(4):389-99. PubMed ID: 15765254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression.
    Rudolph I; Palombo-Kinne E; Kirsch B; Mellinger U; Breitbarth H; Gräser T
    Climacteric; 2004 Sep; 7(3):301-11. PubMed ID: 15669555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
    Georgiev DB; Manassiev NA
    Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy.
    Golgeli A; Tanriverdi F; Suer C; Gokce C; Ozesmi C; Bayram F; Kelestimur F
    Eur J Endocrinol; 2004 Feb; 150(2):153-9. PubMed ID: 14763913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women.
    Endrikat J; Lange E; Kunz M; Schmidt W; Graeser T
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):229-39. PubMed ID: 17763261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of estradiol valerate/dienogest.
    Teichmann A
    Climacteric; 2003 Aug; 6 Suppl 2():17-23. PubMed ID: 14669840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects.
    Semlitsch HV; Anderer P; Saletu B
    Eur J Clin Pharmacol; 1995; 49(3):183-91. PubMed ID: 8665994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive psychophysiology in nootropic drug research: effects of Ginkgo biloba on event-related potentials (P300) in age-associated memory impairment.
    Semlitsch HV; Anderer P; Saletu B; Binder GA; Decker KA
    Pharmacopsychiatry; 1995 Jul; 28(4):134-42. PubMed ID: 7491367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long latency auditory evoked potentials in schoolchildren and adolescents with epilepsy].
    Zgorzalewicz M
    Przegl Lek; 2006; 63 Suppl 1():8-13. PubMed ID: 17471817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multichannel auditory event-related brain potentials: effects of normal aging on the scalp distribution of N1, P2, N2 and P300 latencies and amplitudes.
    Anderer P; Semlitsch HV; Saletu B
    Electroencephalogr Clin Neurophysiol; 1996 Nov; 99(5):458-72. PubMed ID: 9020805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial.
    Jensen JT; Parke S; Mellinger U; Machlitt A; Fraser IS
    Obstet Gynecol; 2011 Apr; 117(4):777-787. PubMed ID: 21422847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.